Show channels:
All channels
Bladder cancer
Brain and spinal
Breast cancer
Cervical
Colon & rectal
Dermatological
General Information
Gynecological
Head and Neck
Kidney/adrenal
Liver
Lung
Lymphoma
Multiple Myeloma
Myelodysplastic syndromes
Myeloproliferative disorders
Pancreas
Pediatric
Prostate
Sarcoma
Stomach
Testicular
Thyroid
Upper aerodigestive
Found 15757 articles
Reflex BRCA1 and BRCA2 tumour genetic testing for high-grade serous ovarian cancer: streamlined for clinicians but what do patients think?
Most (83.5%) participants reported being satisfied/highly satisfied with having tumour testing completed.
»
04/13/22
Vegetable and fruit consumption and cancer of unknown primary risk: results from the Netherlands cohort study on diet and cancer
Inverse association between consumption of raw leafy vegetables and CUP.
»
04/13/22
HOX and PBX gene dysregulation as a therapeutic target in glioblastoma multiforme
Systemic delivery of HTL-001 resulted in improved control of subcutaneous murine and human xenograft tumours.
»
04/13/22
Parenchyma-sparing strategy and oncological prognosis in patients with colorectal cancer liver metastases
Parenchyma-sparing surgery should be priority.
»
04/17/22
Evaluation of mutagenesis, necrosis and apoptosis induced by omeprazole in stomach cells of patients with gastritis
OME cytogenetic instability associated with H. pylori infection.
»
04/18/22
Epidemiology and risk factors for the development of cutaneous toxicities in patients treated with immune-checkpoint inhibitors: A United States population-level analysis.
Patients with melanoma and renal cell carcinoma and those receiving combination therapy at higher risk.
»
09/01/20
Risk of metabolic and cardiovascular adverse events with abiraterone or enzalutamide among men with advanced prostate cancer.
Men receiving abiraterone at increased risk.
»
11/05/21
Neoadjuvant Nivolumab plus Chemotherapy in Resectable Lung Cancer.
Median event-free survival 31.6 months.
»
04/11/22
SEMA6A/RhoA/YAP axis mediates tumor-stroma interactions and prevents response to dual BRAF/MEK inhibition in BRAF-mutant melanoma
SEMA6A prognostic indicator in BRAF-mut melanoma.
»
04/19/22
PTHrP induces STAT5 activation, secretory differentiation and accelerates mammary tumor development
PTHrP acts in cell-autonomous, intracrine manner.
»
04/19/22
< Prev
Next >